1. A quantitative mechanistic PK/PD model directly connects Btk target engagement and in vivo efficacy. Issue 5 (24th March 2017) Authors: Daryaee, Fereidoon; Zhang, Zhuo; Gogarty, Kayla R.; Li, Yong; Merino, Jonathan; Fisher, Stewart L.; Tonge, Peter J. Journal: Chemical science Issue: Volume 8:Issue 5(2017) Page Start: 3434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Correlating drug–target kinetics and in vivo pharmacodynamics: long residence time inhibitors of the FabI enoyl-ACP reductase. Issue 9 (6th June 2016) Authors: Daryaee, Fereidoon; Chang, Andrew; Schiebel, Johannes; Lu, Yang; Zhang, Zhuo; Kapilashrami, Kanishk; Walker, Stephen G.; Kisker, Caroline; Sotriffer, Christoph A.; Fisher, Stewart L.; Tonge, Peter J. Journal: Chemical science Issue: Volume 7:Issue 9(2016:Sep.) Page Start: 5945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetic–pharmacodynamic models that incorporate drug–target binding kinetics. (June 2019) Authors: Daryaee, Fereidoon; Tonge, Peter J Journal: Current opinion in chemical biology Issue: Volume 50(2019) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗